Pieris Pharmaceuticals, Inc.
PIRS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,065 | -$24,543 | -$33,277 | -$45,738 |
| Dep. & Amort. | $0 | $1,781 | $2,780 | $2,368 |
| Deferred Tax | $0 | -$4,518 | $0 | $0 |
| Stock-Based Comp. | $830 | $3,349 | $4,402 | $5,215 |
| Change in WC | $0 | -$7,385 | -$33,370 | $30,525 |
| Other Non-Cash | -$5,605 | -$22,503 | -$467 | -$30 |
| Operating Cash Flow | -$10,840 | -$53,819 | -$59,932 | -$7,660 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$171 | -$1,041 | -$949 |
| Net Acquisitions | $0 | -$12,173 | $20,195 | $0 |
| Inv. Purchases | $0 | -$22,835 | -$48,395 | $0 |
| Inv. Sales/Matur. | $0 | $35,008 | $28,200 | $0 |
| Other Inv. Act. | $0 | $12,173 | -$20,195 | $0 |
| Investing Cash Flow | $0 | $12,002 | -$21,236 | -$949 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $19,795 | $6,922 | $57,101 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $87,089 | $19,795 | $292 | $2,026 |
| Financing Cash Flow | $87,089 | $19,795 | $7,214 | $59,127 |
| Forex Effect | $3 | $783 | -$5,175 | -$3,190 |
| Net Chg. in Cash | $76,252 | -$21,239 | -$79,129 | $47,328 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,350 | $38,635 | $117,764 | $70,436 |
| End Cash | $83,602 | $17,396 | $38,635 | $117,764 |
| Free Cash Flow | -$10,840 | -$53,990 | -$60,973 | -$8,609 |